*David Barton3, Andrea Puig2, Jarrad King2, Ian Hickie1 (1. Brain and Mind Centre, The University of Sydney, Sydney, Australia, 2. Janssen, Sydney, NSW, Australia, 3. Neurocentrix, Noble Park, Melbourne, Australia)
セッション情報
[CINP2024] Short Communications
CINP2024 » Short Communications
Short Communications 3
Depression 1 - Clinical (1)
2024年5月24日(金) 10:45 〜 12:10 Room 8 (G405)
Chair: Michael Berk (Deakin University)
*Manfred Kloebl1,2, Matej Murgaš 1,2, Murray Bruce Reed1,2, Leo Silberbauer1,2, Annette M Hartmann1,2, Godber Mathis Godbersen1,2, Andreas Hahn1,2, Gregor Gryglewski1,2,3, Dan Rujescu1,2, Rupert Lanzenberger1,2 (1. Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 2. Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria, 3. Child Study Center, Yale University, New Haven, CT, USA)
*Zubin Bhagwagar1, Susan G. Kozauer1, Willie R. Earley1, Changzheng Chen1, Jason Huo1, Stephen Stahl2, Roger S. McIntyre3,4, Suresh Durgam1 (1. Intra-Cellular Therapies Inc., New York, NY, USA, 2. Department of Psychiatry, University of California, San Diego; La Jolla, CA, USA, 3. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4. Department of Pharmacology, University of Toronto, Toronto, ON, Canada)
Tim Gheysens1,2, Filip Van Den Eede1,3, *Livia De Picker1,2 (1. Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium, 2. Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Centre Campus Duffel, Duffel, Belgium, 3. Department of Psychiatry, Antwerp University Hospital, Edegem (Antwerp), Belgium)
*Sofia Pappa1,2, Moulesh Shah3, Sophie Young3, Tazneem Anwar4, Timothy Ming4 (1. Department of Brain Sciences, Faculty of Medicine, Imperial College, London, United Kingdom, 2. West London NHS Trust, London, United Kingdom, 3. Imperial College Health Partners, London, United Kingdom, 4. Janssen Cilag Limited, United Kingdom)
*Andre Campiolo Boin1, Luis Felipe Scarabelot1, Camila Marcelino Loureiro1, Daiane Leite Roza2, Frederico Guilherme Graeff1, Cristina Marta Del-Ben1 (1. Neuroscience and Behavior Department Ribeirão Preto Medical School, University of São Paulo, Brazil, 2. Department of Epidemiology, School of Public HealthPublic Health School, University of São Paulo, Brazil)
*Mu-Hong Chen1,2, Hui-Ju Wu1 (1. Taipei Veterans General Hospital, 2. National Yang Ming Chiao Tung University)